{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:26:08Z","timestamp":1778055968501,"version":"3.51.4"},"reference-count":68,"publisher":"Impact Journals, LLC","issue":"38","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,12,1]]},"DOI":"10.18632\/oncotarget.5715","type":"journal-article","created":{"date-parts":[[2015,11,7]],"date-time":"2015-11-07T12:59:51Z","timestamp":1446901191000},"page":"40981-40997","source":"Crossref","is-referenced-by-count":11,"title":["The Hsp90 inhibitor SNX-7081 is synergistic with fludarabine nucleoside via DNA damage and repair mechanisms in human, p53-negative chronic lymphocytic leukemia"],"prefix":"10.18632","volume":"6","author":[{"given":"Kimberley L.","family":"Kaufman","sequence":"first","affiliation":[{"name":"School of Molecular Bioscience, University of Sydney, Darlington, NSW 2006, Australia"},{"name":"Molecular Neuropathology, Brain and Mind Centre, Camperdown, NSW 2050, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiping","family":"Jenkins","sequence":"additional","affiliation":[{"name":"School of Molecular Bioscience, University of Sydney, Darlington, NSW 2006, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munther","family":"Alomari","sequence":"additional","affiliation":[{"name":"School of Molecular Bioscience, University of Sydney, Darlington, NSW 2006, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Mirzaei","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biomolecular Sciences, Macquarie University, North Ryde, NSW 2109, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. Giles","family":"Best","sequence":"additional","affiliation":[{"name":"Northern Blood Research Centre, Kolling Institute for Medical Research, Royal North Shore Hospital, St Leonards, NSW 2065, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Pascovici","sequence":"additional","affiliation":[{"name":"Australian Proteome Analysis Facility, Macquarie University, North Ryde, NSW 2109, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swetlana","family":"Mactier","sequence":"additional","affiliation":[{"name":"School of Molecular Bioscience, University of Sydney, Darlington, NSW 2006, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen P.","family":"Mulligan","sequence":"additional","affiliation":[{"name":"Northern Blood Research Centre, Kolling Institute for Medical Research, Royal North Shore Hospital, St Leonards, NSW 2065, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Haynes","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biomolecular Sciences, Macquarie University, North Ryde, NSW 2109, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard I.","family":"Christopherson","sequence":"additional","affiliation":[{"name":"School of Molecular Bioscience, University of Sydney, Darlington, NSW 2006, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2015,11,6]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood-2008-04-154070","article-title":"Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up","volume":"112","author":"Stilgenbauer","year":"2008","journal-title":"Blood"},{"key":"2","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1021\/pr100803b","article-title":"Comprehensive proteomic analysis of the effects of purine analogs on human Raji B-cell lymphoma","volume":"10","author":"Christopherson","year":"2011","journal-title":"J Proteome Res"},{"key":"3","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1038\/sj.onc.1202576","article-title":"Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress","volume":"17","author":"Fornace","year":"1998","journal-title":"Oncogene"},{"key":"4","first-page":"3741","article-title":"p53-Mediated down-regulation of the human DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) via interaction with Sp1 transcription factor","volume":"29","author":"Bhakat","year":"2009","journal-title":"Anticancer Res"},{"key":"5","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S1568-7864(03)00087-9","article-title":"p53 and regulation of DNA damage recognition during nucleotide excision repair","volume":"2","author":"Ford","year":"2003","journal-title":"DNA Repair (Amst)"},{"key":"6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.18632\/aging.100010","article-title":"Longevity regulation in flies: a role for p53","volume":"1","author":"Donehower","year":"2009","journal-title":"Aging (Albany NY)"},{"key":"7","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood.V84.9.3148.3148","article-title":"p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies","volume":"84","author":"Fenaux","year":"1994","journal-title":"Blood"},{"key":"8","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1182\/blood.V84.10.3440.3440","article-title":"Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, camptothecin analogs","volume":"84","author":"Potmesil","year":"1994","journal-title":"Blood"},{"key":"9","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0968-0004(00)89093-3","article-title":"Cellular responses to DNA damage: cell-cycle checkpoints, apoptosis and the roles of p53 and ATM","volume":"20","author":"Norbury","year":"1995","journal-title":"Trends Biochem Sci"},{"key":"10","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.3109\/10428194.2011.647310","article-title":"The Hsp90 inhibitor SNX-7081 synergizes with and restores sensitivity to fludarabine in chronic lymphocytic leukemia cells with lesions in the TP53 pathway: a potential treatment strategy for fludarabine refractory disease","volume":"53","author":"Mulligan","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"11","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/annonc\/mdg316","article-title":"The Hsp90 chaperone complex as a novel target for cancer therapy","volume":"14","author":"Erlichman","year":"2003","journal-title":"Ann Oncol"},{"key":"12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bbrc.2007.08.054","article-title":"Hsp90\u2014from signal transduction to cell transformation","volume":"363","author":"Tucker","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1517\/14712598.2.1.3","article-title":"HSP90 as a new therapeutic target for cancer therapy: the story unfolds","volume":"2","author":"Workman","year":"2002","journal-title":"Expert Opin Biol Ther"},{"key":"14","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2174\/156802609789895728","article-title":"Update on Hsp90 inhibitors in clinical trial","volume":"9","author":"Trepel","year":"2009","journal-title":"Curr Top Med Chem"},{"key":"15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2141.2010.08348.x","article-title":"The novel Hsp-90 inhibitor SNX7081 is significantly more potent than 17-AAG against primary CLL cells and a range of haematological cell lines, irrespective of lesions in the TP53 pathway","volume":"151","author":"Mulligan","year":"2010","journal-title":"Br J Haematol"},{"key":"16","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1021\/pr301055y","article-title":"The Hsp90 inhibitor SNX-7081, dysregulates proteins involved with DNA repair and replication and the cell cycle in human chronic lymphocytic leukemia (CLL) cells","volume":"12","author":"Christopherson","year":"2013","journal-title":"J Proteome Res"},{"key":"17","doi-asserted-by":"crossref","first-page":"6831","DOI":"10.1158\/1078-0432.CCR-11-0821","article-title":"A phase I study of PF-04929113 (SNX-5422), an orally bioavailable heat shock protein 90 inhibitor, in patients with refractory solid tumor malignancies and lymphomas","volume":"17","author":"Houk","year":"2011","journal-title":"Clin Cancer Res"},{"key":"18","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/sj.leu.2404929","article-title":"Multiple forms of nuclear p53 formed in human Raji and MEC1 cells treated with fludarabine","volume":"22","author":"Christopherson","year":"2008","journal-title":"Leukemia"},{"key":"19","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/leu.2010.6","article-title":"gammaH2AX: a sensitive molecular marker of DNA damage and repair","volume":"24","author":"Karagiannis","year":"2010","journal-title":"Leukemia"},{"key":"20","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/15257770.2011.603716","article-title":"Fludarabine nucleoside modulates nuclear \u201csurvival and death\u201d proteins in resistant chronic lymphocytic leukemia cells","volume":"30","author":"Christopherson","year":"2011","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1476-4598-9-115","article-title":"Determination of genes and microRNAs involved in the resistance to fludarabinein chronic lymphocytic leukemia","volume":"9","author":"Delmer","year":"2010","journal-title":"Mol Cancer"},{"key":"22","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1182\/blood-2014-10-607036","article-title":"Stromal cell-mediated glycolytic switch in CLL cells involves Notch-c-Myc signaling","volume":"125","author":"Mougiakakos","year":"2015","journal-title":"Blood"},{"key":"23","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1038\/sj.onc.1202592","article-title":"The proto-oncogene c-myc and apoptosis","volume":"17","author":"Liebermann","year":"1998","journal-title":"Oncogene"},{"key":"24","first-page":"175","article-title":"Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis","volume":"11","author":"McDonnell","year":"1995","journal-title":"Oncogene"},{"key":"25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/onc.2013.10","article-title":"NF-kappaB is a critical mediator of BRCA1-induced chemoresistance","volume":"33","author":"Harkin","year":"2014","journal-title":"Oncogene"},{"key":"26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.molcel.2013.10.028","article-title":"The BRCA1\/BARD1-interacting protein OLA1 functions in centrosome regulation","volume":"53","author":"Chiba","year":"2014","journal-title":"Mol Cell"},{"key":"27","doi-asserted-by":"crossref","first-page":"8656","DOI":"10.1128\/MCB.25.19.8656-8668.2005","article-title":"Centrosomal microtubule nucleation activity is inhibited by BRCA1-dependent ubiquitination","volume":"25","author":"Parvin","year":"2005","journal-title":"Mol Cell Biol"},{"key":"28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1101\/gad.1381306","article-title":"Multifactorial contributions to an acute DNA damage response by BRCA1\/BARD1-containing complexes","volume":"20","author":"Livingston","year":"2006","journal-title":"Genes Dev"},{"key":"29","first-page":"205","article-title":"BRCA1--a good predictive marker of drug sensitivity in breast cancer treatment?","volume":"1766","author":"Harkin","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"30","first-page":"6221","article-title":"BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis","volume":"63","author":"Harkin","year":"2003","journal-title":"Cancer Res"},{"key":"31","doi-asserted-by":"crossref","first-page":"7078","DOI":"10.1158\/0008-5472.CAN-07-0601","article-title":"BRCA1- and BRCA2-deficient cells are sensitive to etoposide-induced DNA double-strand breaks via topoisomerase II","volume":"67","author":"Powell","year":"2007","journal-title":"Cancer Res"},{"key":"32","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1158\/1078-0432.CCR-07-1083","article-title":"BRCA1 mRNA expression levels predict for overall survival in ovarian cancer after chemotherapy","volume":"13","author":"Harkin","year":"2007","journal-title":"Clin Cancer Res"},{"key":"33","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1111\/j.1582-4934.2009.00824.x","article-title":"The ubiquitin-proteasome system in cancer, a major player in DNA repair. Part 1: post-translational regulation","volume":"13","author":"Papandreou","year":"2009","journal-title":"J Cell Mol Med"},{"key":"34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2008.12.030","article-title":"The vital link between the ubiquitin-proteasome pathway and DNA repair: impact on cancer therapy","volume":"283","author":"Takeda","year":"2009","journal-title":"Cancer Lett"},{"key":"35","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.jprot.2011.11.032","article-title":"The phosphoinositide 3-kinase inhibitor LY294002, decreases aminoacyl-tRNA synthetases, chaperones and glycolytic enzymes in human HT-29 colorectal cancer cells","volume":"75","author":"Christopherson","year":"2012","journal-title":"J Proteomics"},{"key":"36","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.molcel.2014.09.006","article-title":"Oxidative stress diverts tRNA synthetase to nucleus for protection against DNA damage","volume":"56","author":"Yang","year":"2014","journal-title":"Mol Cell"},{"key":"37","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1101\/gad.2021311","article-title":"Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications","volume":"25","author":"Jackson","year":"2011","journal-title":"Genes Dev"},{"key":"38","doi-asserted-by":"crossref","first-page":"39408","DOI":"10.1074\/jbc.M406432200","article-title":"Non-homologous end joining requires that the DNA-PK complex undergo an autophosphorylation-dependent rearrangement at DNA ends","volume":"279","author":"Ramsden","year":"2004","journal-title":"J Biol Chem"},{"key":"39","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1002\/j.1460-2075.1994.tb06826.x","article-title":"Human DNA helicase II: a novel DNA unwinding enzyme identified as the Ku autoantigen","volume":"13","author":"Chen","year":"1994","journal-title":"EMBO J"},{"key":"40","doi-asserted-by":"crossref","first-page":"8593","DOI":"10.1074\/jbc.271.15.8593","article-title":"The interaction between Ku antigen and REF1 protein mediates negative gene regulation by extracellular calcium","volume":"271","author":"Okazaki","year":"1996","journal-title":"J Biol Chem"},{"key":"41","doi-asserted-by":"crossref","first-page":"37280","DOI":"10.1074\/jbc.M206482200","article-title":"Regulation of osteocalcin gene expression by a novel Ku antigen transcription factor complex","volume":"277","author":"Towler","year":"2002","journal-title":"J Biol Chem"},{"key":"42","doi-asserted-by":"crossref","first-page":"36498","DOI":"10.1074\/jbc.C000513200","article-title":"Functional interaction of proliferating cell nuclear antigen with MSH2-MSH6 and MSH2-MSH3 complexes","volume":"275","author":"Kunkel","year":"2000","journal-title":"J Biol Chem"},{"key":"43","doi-asserted-by":"crossref","first-page":"40362","DOI":"10.1074\/jbc.M206194200","article-title":"A proteomics approach to identify proliferating cell nuclear antigen (PCNA)-binding proteins in human cell lysates. Identification of the human CHL12\/RFCs2-5 complex as a novel PCNA-binding protein","volume":"277","author":"Tsurimoto","year":"2002","journal-title":"J Biol Chem"},{"key":"44","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1101\/gad.191201","article-title":"hMSH3 and hMSH6 interact with PCNA and colocalize with it to replication foci","volume":"15","author":"Jiricny","year":"2001","journal-title":"Genes Dev"},{"key":"45","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1101\/gad.14.8.927","article-title":"BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures","volume":"14","author":"Qin","year":"2000","journal-title":"Genes Dev"},{"key":"46","doi-asserted-by":"crossref","first-page":"11236","DOI":"10.1073\/pnas.201373498","article-title":"Purification and characterization of human DNA damage checkpoint Rad complexes","volume":"98","author":"Sancar","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"47","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/gtc.12040","article-title":"Loading and activation of DNA replicative helicases: the key step of initiation of DNA replication","volume":"18","author":"Araki","year":"2013","journal-title":"Genes Cells"},{"key":"48","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/bies.20089","article-title":"PML nuclear bodies: dynamic sensors of DNA damage and cellular stress","volume":"26","author":"Bazett-Jones","year":"2004","journal-title":"Bioessays"},{"key":"49","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1038\/sj.onc.1208338","article-title":"PML interacts with Myc, Myc target gene expression is altered in PML-null fibroblasts","volume":"24","author":"Meroni","year":"2005","journal-title":"Oncogene"},{"key":"50","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrm831","article-title":"Cellular roles of DNA topoisomerases: a molecular perspective","volume":"3","author":"Wang","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"51","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","article-title":"DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139","volume":"273","author":"Bonner","year":"1998","journal-title":"J Biol Chem"},{"key":"52","doi-asserted-by":"crossref","first-page":"e103680","DOI":"10.1371\/journal.pone.0103680","article-title":"Inhibition of Hsp90 augments docetaxel therapy in castrate resistant prostate cancer","volume":"9","author":"Pili","year":"2014","journal-title":"PLoS One"},{"key":"53","first-page":"105","article-title":"Hsp90 inhibition increases p53 expression and destabilizes MYCN and MYC in neuroblastoma","volume":"38","author":"Tang","year":"2011","journal-title":"Int J Oncol"},{"key":"54","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/1947601910378025","article-title":"Myc Regulation of mRNA Cap Methylation","volume":"1","author":"Cole","year":"2010","journal-title":"Genes Cancer"},{"key":"55","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/1471-2407-10-348","article-title":"Myc suppression of Nfkb2 accelerates lymphomagenesis","volume":"10","author":"Cleveland","year":"2010","journal-title":"BMC Cancer"},{"key":"56","doi-asserted-by":"crossref","first-page":"189","DOI":"10.14348\/molcells.2014.2353","article-title":"NF-kappaB in cellular senescence and cancer treatment","volume":"37","author":"Lee","year":"2014","journal-title":"Mol Cells"},{"key":"57","first-page":"106","article-title":"Accumulation of NFkB1 (p105) and NFkB2 (p100) Is Essential for Apoptosis Induced by Proteasome Inhibition in a Lymphoma Model","author":"Ratner","year":"2005","journal-title":"Blood"},{"key":"58","doi-asserted-by":"crossref","first-page":"525","DOI":"10.18632\/oncotarget.491","article-title":"The Hsp90 inhibitor NVP-AUY922-AG inhibits NF-kappaB signaling, overcomes microenvironmental cytoprotection and is highly synergistic with fludarabine in primary CLL cells","volume":"3","author":"Pepper","year":"2012","journal-title":"Oncotarget"},{"key":"59","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.7314\/APJCP.2015.16.8.3301","article-title":"Knocking Down Nucleolin Expression Enhances the Radiosensitivity of Non-Small Cell Lung Cancer by Influencing DNA-PKcs Activity","volume":"16","author":"Chang","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"60","doi-asserted-by":"crossref","first-page":"8572","DOI":"10.1074\/jbc.M207637200","article-title":"Apoptosis in leukemia cells is accompanied by alterations in the levels and localization of nucleolin","volume":"278","author":"Bates","year":"2003","journal-title":"J Biol Chem"},{"key":"61","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.1182\/blood-2012-12-471094","article-title":"Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosisvia a surface nucleolin-Fas complex","volume":"121","author":"Samaniego","year":"2013","journal-title":"Blood"},{"key":"62","doi-asserted-by":"crossref","first-page":"43816","DOI":"10.1074\/jbc.M111.310979","article-title":"Heat shock protein 90 stabilizes nucleolin to increase mRNA stability in mitosis","volume":"286","author":"Hung","year":"2011","journal-title":"J Biol Chem"},{"key":"63","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0145-2126(98)00154-4","article-title":"MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation","volume":"23","author":"Caligaris-Cappio","year":"1999","journal-title":"Leuk Res"},{"key":"64","first-page":"197","article-title":"Differential upregulation of p53-responsive genes by genotoxic stress in hematopoietic cells containing wild-type and mutant p53","volume":"8","author":"Almasan","year":"1999","journal-title":"Gene Expr"},{"key":"65","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1021\/pr2008779","article-title":"Shotgun proteomic analysis of long-distance drought signaling in rice roots","volume":"11","author":"Atwell","year":"2012","journal-title":"J Proteome Res"},{"key":"66","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1021\/pr060161n","article-title":"Statistical analysis of membrane proteome expression changes in","volume":"5","author":"Washburn","year":"2006","journal-title":"J. Prot. Res"},{"key":"67","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-1-62703-360-2_17","article-title":"Label-free quantitative shotgun proteomics using normalized spectral abundance factors","volume":"1002","author":"Haynes","year":"2013","journal-title":"Methods Mol Biol"},{"key":"68","volume-title":"Handbook of Biological Statistics","author":"McDonald","year":"2009","edition":"2"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5715","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T16:36:30Z","timestamp":1653496590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,6]]},"references-count":68,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2015,12,1]]}},"alternative-id":["5715","26556860"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.5715","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,6]]}}}